Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$372.0 - $424.34 $155,124 - $176,949
-417 Reduced 23.53%
1,355 $558,000
Q1 2024

Apr 18, 2024

SELL
$284.87 - $413.31 $172,631 - $250,465
-606 Reduced 25.48%
1,772 $716,000
Q4 2023

Jan 08, 2024

SELL
$227.52 - $312.68 $682 - $938
-3 Reduced 0.13%
2,378 $728,000
Q3 2023

Nov 17, 2023

BUY
$233.98 - $281.67 $701 - $845
3 Added 0.13%
2,381 $576,000
Q2 2023

Jul 18, 2023

BUY
$187.26 - $240.17 $138,946 - $178,206
742 Added 45.35%
2,378 $571,000
Q1 2023

Apr 07, 2023

BUY
$174.31 - $239.52 $93,430 - $128,382
536 Added 48.73%
1,636 $307,000
Q4 2022

Jan 17, 2023

BUY
$153.06 - $226.57 $168,366 - $249,227
1,100 New
1,100 $234,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.